Polio

InDevR Launches ArrayMax Mixer for Even Faster VaxArray Assay Times

Retrieved on: 
Tuesday, November 16, 2021

BOULDER, Colo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its new ArrayMaxTM Mixer to provide significantly reduced assay times for its VaxArray Portfolio of immunoassay kits.

Key Points: 
  • BOULDER, Colo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its new ArrayMaxTM Mixer to provide significantly reduced assay times for its VaxArray Portfolio of immunoassay kits.
  • Current VaxArray Assays include kits for influenza, coronavirus, measles/rubella, and polio, and provide vaccine manufacturers faster characterization of identity, quantity, and stability parameters during manufacture and release of vaccine products.The ArrayMax Mixer significantly improves mixing over static incubation or traditional orbital shakers during assay execution using either antibody or antigen samples.In internal validation studies comparing ArrayMax to original VaxArray protocols, similar or improved analytical performance was obtained using new ArrayMax-executed VaxArray protocols and up to an 85% reduction of time to result was obtained.
  • In a small 6"x 6" footprint, this convenient new tool provides the possibility to generate VaxArray results in a fraction of the time compared to traditional ELISA, providing a total assay time of less than onehour for currently available VaxArray Kits.
  • Erica Dawson, CTO of InDevR, noted, "Our VaxArray Assay Kits already provide significant advantages over outdated, laborious, and error prone techniques such as SRID, TCID50, and ELISAs.This further reduction in total assay time for the VaxArray Kits will benefit any vaccine development or manufacturer in bioprocess development, optimization and monitoring, as well as vaccine release testing.We are excited to continue empowering vaccine producers by further expanding our portfolio."

PharmaJet Presents How to Improve Vaccine Performance with Needle-free Delivery at Vaccine World Asia Congress

Retrieved on: 
Monday, November 15, 2021

PharmaJet , the maker of innovative, needle-free injection technology, announced that their latest research results will be presented at the Vaccine World Asia Congress 2021 on November 17.

Key Points: 
  • PharmaJet , the maker of innovative, needle-free injection technology, announced that their latest research results will be presented at the Vaccine World Asia Congress 2021 on November 17.
  • The presentation, entitled Improving Vaccine Performance with Needle-free Delivery, is being presented by Paul LaBarre, MS, MBA, Vice President, Global Business Development.
  • The vaccine will be delivered exclusively with the PharmaJet Tropis Intradermal Needle-free Injection System.
  • PharmaJets mission is worldwide acceptance of PharmaJet needle-free devices as a standard of care in the vaccine delivery market.

March Of Dimes 2021 Report Card Examines State Of Maternal And Infant Health In Louisiana

Retrieved on: 
Monday, November 15, 2021

In Louisiana, the preterm birth rate fell from 13.1% to 12.9% in 2020, earning the state an F grade on this year's Report Card.

Key Points: 
  • In Louisiana, the preterm birth rate fell from 13.1% to 12.9% in 2020, earning the state an F grade on this year's Report Card.
  • The Report Card highlights the stark disparities that cut across all measures of maternal and infant health and outlines the policy actions and partnerships needed to improve the health of our nation's families.
  • A challenge as complex as thematernal and infant health crisisinShreveport, for example, requires the dedication and resources of cross-sector partners working together.
  • Before becoming leaders in maternal and infant health, March of Dimes was known for conquering the polio epidemic (Historical footage and photos available).

March Of Dimes 2021 Report Card Examines State Of Maternal And Infant Health In Georgia

Retrieved on: 
Monday, November 15, 2021

In Georgia, the preterm birth rate fell from 11.7% to 11.4% in 2020, earning the state a D- grade on this year's Report Card.

Key Points: 
  • In Georgia, the preterm birth rate fell from 11.7% to 11.4% in 2020, earning the state a D- grade on this year's Report Card.
  • The Report Card highlights the stark disparities that cut across all measures of maternal and infant health and outlines the policy actions and partnerships needed to improve the health of our nation's families.
  • A challenge as complex as thematernal and infant health crisisinAtlanta, for example, requires the dedication and resources of cross-sector partners working together.
  • Before becoming leaders in maternal and infant health, March of Dimes was known for conquering the polio epidemic (Historical footage and photos available).

March Of Dimes 2021 Report Card Examines State Of Maternal And Infant Health In Texas

Retrieved on: 
Monday, November 15, 2021

The Report Card highlights the stark disparities that cut across all measures of maternal and infant health and outlines the policy actions and partnerships needed to improve the health of our nation's families.

Key Points: 
  • The Report Card highlights the stark disparities that cut across all measures of maternal and infant health and outlines the policy actions and partnerships needed to improve the health of our nation's families.
  • A challenge as complex as thematernal and infant health crisisinHouston and San Antonio, for example, requires the dedication and resources of cross-sector partners working together.
  • For example, the Texas Report Card shows direct entry midwives and certified nurse midwives are allowed to practice in the state.
  • Before becoming leaders in maternal and infant health, March of Dimes was known for conquering the polio epidemic (Historical footage and photos available).

March Of Dimes 2021 Report Card Examines State Of Maternal And Infant Health In Florida

Retrieved on: 
Monday, November 15, 2021

In Florida, preterm births decreased slightly from 10.6% to 10.5% in 2020, again earning the state a D+ grade on this year's Report Card.

Key Points: 
  • In Florida, preterm births decreased slightly from 10.6% to 10.5% in 2020, again earning the state a D+ grade on this year's Report Card.
  • The Report Card highlights the stark disparities that cut across all measures of maternal and infant health and outlines the policy actions and partnerships needed to improve the health of our nation's families.
  • For example, the Florida Report Card shows direct entry midwives and certified nurse midwives are allowed to practice in the state.
  • Before becoming leaders in maternal and infant health, March of Dimes was known for conquering the polio epidemic (Historical footage and photos available).

Global Ultraviolet Disinfection Equipment Market 2021: Municipal End Users are Expected to Project the Largest Market Share - ResearchAndMarkets.com

Retrieved on: 
Monday, November 1, 2021

The Ultraviolet Disinfection Equipment market size is expected to register a CAGR of 11.2% over the forecast period, 2021-2026.

Key Points: 
  • The Ultraviolet Disinfection Equipment market size is expected to register a CAGR of 11.2% over the forecast period, 2021-2026.
  • The recent outbreak of COVID-19 is expected to boost the Ultraviolet disinfection equipment market share in the medium to long run.
  • Such extreme circumstances drive the need for Ultraviolet disinfection equipment, considering the economic factor associated with developing countries and effective solutions offered by UV disinfection systems.
  • March 2021 - Evoque Water Technologies expands its global presence in Chennai, India, due to the increasing growth of the Asia-Pacific market.

Sabin Vaccine Institute Receives Additional $34.5 Million from BARDA for Further Development of Ebola Sudan and Marburg Vaccines

Retrieved on: 
Thursday, October 21, 2021

In September 2019, BARDA awarded Sabin a development contract, valued up to $128 million, and has already provided funding of $40.5 million.

Key Points: 
  • In September 2019, BARDA awarded Sabin a development contract, valued up to $128 million, and has already provided funding of $40.5 million.
  • The two candidate vaccines, based on GSKs proprietary ChAd3 platform, were exclusively licensed to the Sabin Vaccine Institute from GSK in 2019.
  • Ebola Sudan and Marburg are members of the Filoviridae virus family and are commonly referred to as filoviruses.
  • Ebola was identified in 1976 when two simultaneous outbreaks occurred in northern Zaire (now the DRC) in a village near the Ebola River and southern Sudan.

The Alliance for Advancing Health Online Invests $7M+ through the Vaccine Confidence Fund to Boost Vaccination Confidence through Social Media

Retrieved on: 
Thursday, October 14, 2021

VCF is the first flagship program of the Alliance for Advancing Health Online (AAHO).

Key Points: 
  • VCF is the first flagship program of the Alliance for Advancing Health Online (AAHO).
  • The AAHOs mission is to bring together members from the technology, health, global development and academic sectors to advance public understanding of how social media and other online platforms can be leveraged to increase vaccination confidence and vaccine uptake.
  • Supporting the public health efforts to increase vaccine confidence has been our top priority, said KX Jin, Facebooks Head of Health.
  • Finally, more than half of the grantees will be investigating the connection between social media (online) and vaccine uptake (offline) through vaccination bookings and/or actual vaccinations via health clinics.

Iconic Ambu Bag Celebrates a Birthday: 65 Years of Saving Lives

Retrieved on: 
Thursday, October 14, 2021
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211014005554/en/
    The Ambu Bag has come to define the self-inflating manual resuscitation device that is part of the standard kit carried by first responders.
  • Called a quintessential piece of equipment, the Ambu Bag is found in ambulances and throughout hospitals, from the ER to the OR and most places in between.
  • The Ambu Bag is the first resuscitator that worked without a battery or an oxygen supply.
  • Hospitals needed a way to ventilate patients without oxygen and the Ambu Bag was born, revolutionizing manual resuscitation.